167 related articles for article (PubMed ID: 10648038)
1. FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis.
Fuseler JW; Hearth-Holmes M; Grisham MB; Kang D; Laroux FS; Wolf RE
J Rheumatol; 2000 Jan; 27(1):190-9. PubMed ID: 10648038
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
4. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
5. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis.
Fuseler JW; Conner EM; Davis JM; Wolf RE; Grisham MB
Inflammation; 1997 Feb; 21(1):113-31. PubMed ID: 9179627
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy attenuates streptococcal cell wall-induced arthritis and alters leukocyte activation.
Kimpel D; Dayton T; Fuseler J; Gray L; Kannan K; Wolf RE; Grisham M
Arthritis Rheum; 2003 Dec; 48(12):3557-67. PubMed ID: 14674009
[TBL] [Abstract][Full Text] [Related]
8. Kupffer-cell depletion attenuates colonic and extracolonic granulomatous inflammation in chronic colitis.
Yamada T; Takahashi S; Masuda K; Ohara H; Nakazawa T; Sano H; Ando T; Nakamura S; Kobayashi S; Kuno A; Aoki S; Nomura T; Joh T; Itoh M
J Lab Clin Med; 2003 Oct; 142(4):268-77. PubMed ID: 14625533
[TBL] [Abstract][Full Text] [Related]
9. FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: implication of distinct effect from suppression of inflammation.
Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
Int Immunopharmacol; 2005 Mar; 5(3):503-10. PubMed ID: 15683847
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis.
Chen W; Jin W; Cook M; Weiner HL; Wahl SM
J Immunol; 1998 Dec; 161(11):6297-304. PubMed ID: 9834119
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats.
Fletcher DS; Widmer WR; Luell S; Christen A; Orevillo C; Shah S; Visco D
J Pharmacol Exp Ther; 1998 Feb; 284(2):714-21. PubMed ID: 9454819
[TBL] [Abstract][Full Text] [Related]
12. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
13. Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin.
Song XY; Zeng L; Jin W; Pilo CM; Frank ME; Wahl SM
Arthritis Rheum; 2000 Sep; 43(9):2064-72. PubMed ID: 11014358
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine or FK506 in chronic colitis.
Aiko S; Conner EM; Fuseler JA; Grisham MB
J Pharmacol Exp Ther; 1997 Feb; 280(2):1075-84. PubMed ID: 9023326
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
17. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
19. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
